Navigation Links
Stereoscopic mammography could reduce recall rate
Date:11/13/2012

OAK BROOK, Ill. A new three-dimensional (3-D) digital mammography technique has the potential to significantly improve the accuracy of breast cancer screening, according to a study published in Radiology.

Two-dimensional (2-D) x-ray mammography, the current primary screening method for early detection of breast cancer in women, is a valuable tool but has some limitations. Surrounding normal tissue can mask lesions, and 2-D views do not provide direct information about the volumetric appearancemeaning the three-dimensional physical shapeof a detected lesion.

A novel technique called stereoscopic digital mammography (SDM) addresses these limitations by mimicking the way that human eyes work together to form a 3-D image. The technique uses digital mammography equipment that's been modified to allow the X-ray tube to move separately from the cassette. The resulting images are viewed on two monitors mounted one above the other.

"Our eyes see the world from two slightly different perspectives," said Carl J. D'Orsi, M.D., from the Department of Radiology and Imaging Sciences at Emory University School of Medicine and the Winship Cancer Institute at Emory University, both in Atlanta. "In this technique, the X-ray tube functions as the eyeball, with two different images providing slightly different views of the internal structure of the breast."

By using a unique workstation and polarizing lenses, SDM has the ability to identify lesions at different depths within the breast volume, potentially reducing both false positive findings and recalls while enabling more accurate diagnosis.

Dr. D'Orsi and colleagues recently compared SDM to 2-D digital mammography in 779 patients at elevated risk of developing breast cancer because of personal or family history. Patients received both exams in a single visit, and two experienced radiologists independently interpreted the final total of 1,298 exams. Imaging findings were correlated with results of one-year follow up or biopsy.

SDM significantly improved the accuracy of cancer detection. The specificity of 91.2 percent was better than the 87.8 percent rate for 2-D digital mammography; and the accuracy of 90.9 percent, compared with 87.4 percent for 2-D digital mammography, was also a statistically significant improvement.

"We found that the stereoscopic technique could significantly decrease the need for calling women back for additional exams," Dr. D'Orsi said.

Dr. D'Orsi and colleagues are expanding their research to study

SDM with a lower radiation dose in the general screening population. The radiation dose used in the study was approximately double the standard dose for mammography.

"In this study, we used a high-risk population to get an adequate number of cancers, and we acquired each of the images comprising the stereo pairs with a full standard X-ray dose," he said. "Now that we know the technique is worthwhile, we're repeating the study in the general population with a dose comparable to routine screening mammography."


'/>"/>
Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America
Source:Eurekalert

Related medicine news :

1. Women in less affluent areas of Chicago less likely to reside near mammography facility
2. Mammographys Benefits Outweigh Harms for Older Women: Study
3. U.S. Mammography Rates Drop Following Task Force Recommendations
4. Research examines when benefits of screening mammography outweigh the harms for women in their 40s
5. Study finds mammography beneficial for younger women
6. Could iPads, Kindles Be Just What the Eye Doctor Ordered?
7. Testing pain killers on humans could save money and speed the arrival of new drugs
8. New cells found that could help save peoples sight
9. Could an Aging Face Reflect an Unhealthy Heart?
10. Virtual reality could help people lose weight, fight prejudice
11. Cancer data in the cloud could lead to more effective treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... Mateo, CA (PRWEB) , ... April 28, 2017 , ... ... Area cities as diverse as Millbrae, Burlingame, and Palo Alto, is proud to announce ... allow interested persons to bookmark and read organized content on topics such as home ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... nation’s leading respiratory hospital, based in Denver, Colorado, announced an agreement to create ... by the continuing support of the Jane and Leonard Korman Family Foundation. The ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... Gasby the 2017 Public Leadership in Neurology Award (PLINA). The couple joins a ... Tedy Bruschi, Vice President Walter Mondale, actor Michael J. Fox and former U.S. ...
(Date:4/27/2017)... Malibu, CA (PRWEB) , ... April 27, 2017 , ... ... United States with an oil many times purer and more potent than the market ... mountain air of Gstaad, Switzerland, as well as a patented chromatography process for extraction, ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... today released the podcast, “Make Plans for MACRA,” highlighting the impact ... the physician's office and how physicians and other clinicians are reimbursed for the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Zimmer Biomet Holdings, Inc. (NYSE ... today announced that it will be participating in the ... the InterContinental Hotel in Boston, Massachusetts ... present at 11:20 a.m. Eastern Time. A ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com .  ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 Research ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ... to their offering. ... market for drug delivery technologies will rise from USD 20 Billion ... Global Drug Delivery Technologies - Innovation Driven by Rapidly ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
Breaking Medicine Technology: